ATI RN
Pediatric NCLEX Practice Quiz Questions
Question 1 of 5
Patients suffering from the sudden onset of severe neuromuscular symptoms may have nerve agent intoxication and should be given atropine (0.05 mg/kg) promptly for its antimuscarinic effects. Atropine has the following effects EXCEPT
Correct Answer: C
Rationale: In the case of nerve agent intoxication, atropine is administered to counteract the effects of excessive acetylcholine release. The correct answer, C, states that atropine improves skeletal muscle paralysis, which is incorrect. Atropine does not directly affect skeletal muscle paralysis; its primary action is to block muscarinic receptors in the body. Option A, relieving bronchospasm, is a correct effect of atropine as it helps dilate the airways and improve breathing in cases of respiratory distress. Option B, relieving bradycardia, is also a correct effect as atropine increases heart rate by blocking the parasympathetic effects on the heart. Option D, ameliorating diarrhea, is another correct effect of atropine as it reduces gastrointestinal motility and secretions. These effects are crucial in managing symptoms of nerve agent intoxication. In an educational context, understanding the pharmacological effects of atropine is essential for healthcare providers, especially in emergency situations like nerve agent intoxication. Knowing the correct actions of atropine can help in prompt and effective treatment to mitigate the potentially life-threatening effects of nerve agent exposure.
Question 2 of 5
To avoid false-negative skin test results in atopic hosts, most sedating antihistamines should be withheld for 3-4 days, and non-sedating antihistamines for 5-7 days while montelukast should be withheld for
Correct Answer: C
Rationale: In the context of pediatric care and managing atopic hosts, it is crucial to understand the impact of medications on diagnostic testing such as skin tests. The correct answer, option C) 5 days, is the most appropriate timeframe to withhold montelukast before conducting skin tests to avoid false-negative results. Montelukast, a leukotriene receptor antagonist, can affect the results of skin testing due to its mechanism of action on the immune system. Option A) 1 day is too short of a timeframe to ensure montelukast has cleared from the system sufficiently to prevent interference with skin test results. Option B) 3 days is also insufficient given the drug's half-life and mechanism of action. Option D) 7 days is longer than necessary based on the pharmacokinetics of montelukast. Educationally, understanding the timing of medication withdrawal in the context of diagnostic testing is essential for nurses and healthcare providers caring for pediatric patients with atopic conditions. This knowledge ensures accurate test results, leading to appropriate treatment decisions for the child's health. It also highlights the importance of considering drug effects on diagnostic tests, promoting safe and effective clinical practice in pediatric care.
Question 3 of 5
Spirometry is a helpful objective measure of airflow limitation; it depends on the patient's ability to properly perform a full, forceful, and prolonged expiratory maneuver. Spirometry is usually feasible in children
Correct Answer: D
Rationale: The correct answer is D) 2-10 yr of age. Spirometry is a valuable tool in assessing airflow limitation in children. While the technique may be more challenging in younger children due to their limited ability to cooperate, it is generally feasible from the age of 2 years onwards. Option A) 2-4 yr of age is incorrect because it limits the age range too narrowly. By age 4, many children can successfully perform spirometry. Option B) 2-6 yr of age is also too restrictive, excluding older children who may still benefit from spirometry testing. Option C) 2-8 yr of age similarly limits the upper age range, missing the opportunity to assess pulmonary function in children up to 10 years old. In an educational context, it is essential to understand the developmental abilities of children when performing diagnostic tests like spirometry. By recognizing that children as young as 2 years old can undergo spirometry successfully with proper guidance and support, healthcare providers can ensure accurate assessments of respiratory function in pediatric patients.
Question 4 of 5
Use of a stoplight zone system (green, yellow, red) tailored to each child's personal best PEF values can optimize effectiveness and interest. Of the following, the PEF value in the yellow zone is
Correct Answer: D
Rationale: In pediatric asthma management, using a stoplight zone system helps children and caregivers easily understand and respond to changes in peak expiratory flow (PEF) values. The yellow zone indicates caution, signaling a decline in lung function. The correct answer, D) 50-80%, falls within the yellow zone range. This range signifies a moderate decrease in PEF, prompting an action plan adjustment to prevent worsening symptoms. Option A) <10% is incorrect as it represents a severe decrease requiring immediate intervention. Option B) 10-30% is too low for the yellow zone and indicates a mild decrease not warranting immediate action. Option C) 30-50% is also outside the typical yellow zone range, indicating a moderate to severe decline, not just moderate as in the yellow zone. Educationally, understanding PEF zones in asthma management is crucial for tailored care. By recognizing and appropriately responding to PEF values in each zone, healthcare providers and families can proactively manage asthma, preventing exacerbations and improving the child's quality of life. This knowledge empowers caregivers to take timely and effective actions based on objective measurements, promoting better asthma control.
Question 5 of 5
A high index of suspicion of which of the following conditions is to be undertaken in a patient with atopic dermatitis and failure to thrive
Correct Answer: A
Rationale: In a patient with atopic dermatitis and failure to thrive, a high index of suspicion for Wiskott-Aldrich syndrome should be maintained. This is because Wiskott-Aldrich syndrome is a rare X-linked recessive disorder characterized by a triad of eczema, thrombocytopenia, and recurrent infections. Atopic dermatitis is a common manifestation of the disease. Failure to thrive can be attributed to recurrent infections and poor nutritional status due to the immune dysfunction associated with the syndrome. Severe combined immune deficiency (SCID) is characterized by profound defects in both cellular and humoral immunity, leading to severe and recurrent infections. While failure to thrive can be a feature of SCID, the presence of atopic dermatitis in this case points more towards Wiskott-Aldrich syndrome. Histiocytosis is a group of rare disorders involving an overproduction of white blood cells called histiocytes. While it can present with skin manifestations, failure to thrive is not a common feature of this condition. Hyper IgE syndrome, also known as Job syndrome, is characterized by recurrent infections, eczema, and elevated levels of IgE. While it shares some similarities with Wiskott-Aldrich syndrome, failure to thrive is not a typical feature of hyper IgE syndrome. In an educational context, understanding the specific clinical presentations of different pediatric conditions is crucial for accurate diagnosis and management. This question reinforces the importance of recognizing key features of Wiskott-Aldrich syndrome in the context of atopic dermatitis and failure to thrive, guiding healthcare providers to consider this rare but serious condition in their differential diagnosis.